Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
2301studies shown
Showing 1,969-1,980 of 2,301
Behavioral study icon
TerminatedNCT04659993

Cancer Within a Pandemic: A Telemental Health Intervention

This summary needs review. Please check the official study record and contact the research team for details.

In United States
Why is this study shown?

This study includes Depression among several conditions.

Anxiety, DepressionBehavioralFrom 18 Years to 39 Years
Countries
United States
Sponsor
Wake Forest University Health Sciences
Condition
Anxiety, Depression
Drug study icon
WithdrawnNCT04430959

Candesartan as an Adjunctive Treatment for Depression in bipolarity

This study exists to better understand the safety of blood tests and biological markers and how manageable it feels in practice. Researchers are trying to understand how people respond to blood tests and biological markers in practice and what may need to be adjusted.

In United States
Why is this study shown?

This study includes Depression among several conditions.

Bipolarity, DepressionDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United States
Sponsor
The University of Texas Health Science Center, Houston
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT00203567

Carbamazepine Extended-Release for Depression in bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In United States
Why is this study shown?

This study includes Depression among several conditions.

Bipolarity, DepressionDrugFrom 19 Years to 65 Years
Countries
United States
Sponsor
Tuscaloosa Research & Education Advancement Corporation
Condition
Bipolarity, Depression
Other study type icon
SuspendedNCT04603781

CBD Oil for Reducing Emotional Impact of COVID-19

This summary needs review. Please check the official study record and contact the research team for details.

In United States
Why is this study shown?

This study includes Depression among several conditions.

Anxiety, DepressionOtherFrom 18 Years to 70 Years
Countries
United States
Sponsor
University of Texas at Austin
Condition
Anxiety, Depression
Drug study icon
TerminatedNCT00566111

Ceftriaxone in the Management of Depression in bipolarity

This study exists to compare options and see whether a therapy or guided support program offers something meaningfully different. Researchers are trying to understand what a therapy or guided support program could change in day-to-day care and decision-making.

In United States
Why is this study shown?

This study includes Depression among several conditions.

Bipolarity, DepressionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Yale University
Condition
Bipolarity, Depression
Behavioral study icon
CompletedNCT06143852

Change in Social Media Use and Well-being Among College Students Receiving a One-week Exercise or Mindfulness Intervention

This summary needs review. Please check the official study record and contact the research team for details.

In United States
Why is this study shown?

This study includes Depression among several conditions.

Addiction, Depression, ...BehavioralOver 18 Years
Countries
United States
Sponsor
Johns Hopkins Bloomberg School of Public Health
Condition
Addiction, Depression, ...
Other study type icon
CompletedNCT04783506

Characterizing Inflammatory Profiles and Suicide prevention in Adolescents

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

Remote / online
Why is this study shown?

This study includes Depression among several conditions.

Suicidality, DepressionOtherFrom 12 Years to 18 Years
Countries
United States
Sponsor
University of Texas Southwestern Medical Center
Condition
Suicidality, Depression
Behavioral study icon
CompletedNCT01784341

Circadian Phase in Depression in bipolarity: Is it Delayed and Does it Normalize With Remission?

This study exists to compare options and see whether acceptance and commitment therapy, a talking treatment, offers something meaningfully different. Researchers are trying to understand whether acceptance and commitment therapy, a talking treatment, can improve attention, thinking, or day-to-day functioning.

In United States
Why is this study shown?

This study includes Depression among several conditions.

Bipolarity, DepressionOtherFrom 18 Years to 55 Years
Countries
United States
Sponsor
Northwestern University
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT02600494

study Evaluating ITI-007 (Lumateperone) as a Monotherapy for Depression in bipolarity

This study exists to understand how the medication ITI-007 holds up over time after the earliest research stage. Researchers are trying to understand how people respond to the medication ITI-007 in practice and what may need to be adjusted.

In United States
Why is this study shown?

This study includes Depression among several conditions.

Bipolarity, DepressionDrugFrom 18 Years to 75 Years
Countries
United States
Sponsor
Intra-Cellular Therapies, Inc.
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT02600507

Clinical Trial Evaluating ITI-007 as an Adjunctive Therapy to Lithium or Valproate for the Treatment of Depression for depression in bipolarity

This study is completed in the United States, in Bulgaria, in Russia, .... It is testing Clinical Trial Evaluating ITI-007 as an Adjunctive Therapy to Lithium or Valproate for the Treatment of Depression for depression in bipolarity.

In United States
Why is this study shown?

This study includes Depression among several conditions.

Bipolarity, DepressionDrugFrom 18 Years to 75 Years
Countries
United States, Bulgaria, Russia, ...
Sponsor
Intra-Cellular Therapies, Inc.
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT00043654

study of Mifepristone for Depression in bipolarity

This study exists to see whether the medication Mifepristone is workable and worth testing more broadly. Researchers are trying to understand whether the medication Mifepristone can improve attention, thinking, or day-to-day functioning.

In United States
Why is this study shown?

This study includes Depression among several conditions.

Bipolarity, DepressionDrugFrom 18 Years to 75 Years
Countries
United States
Sponsor
National Institute of Mental Health (NIMH)
Condition
Bipolarity, Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.